Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study.
暂无分享,去创建一个
P. Scheltens | B. Vellas | M. O. Olde Rikkert | F. Verhey | R. Witkamp | E. Scarpini | C. V. von Arnim | R. Blesa | P. Kamphuis | J. Sijben | M. Vandewoude | A. Bongers | J. Harrison